Tempest Therapeutics, Inc. (TPST) Free cash flow 2016–2025
Tempest Therapeutics, Inc. (TPST) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$26.8MFY2025 · since FY2016: -$64.3M → -$26.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$26.8M | +19.8% |
| FY2024 | -$33.5M | -21.6% |
| FY2023 | -$27.5M | +13.0% |
| FY2022 | -$31.6M | -21.2% |
| FY2021 | -$26.1M | -36.8% |
| FY2020 | -$19.1M | +54.2% |
| FY2019 | -$41.6M | -75.7% |
| FY2018 | -$23.7M | -16.4% |
| FY2017 | -$20.3M | +68.4% |
| FY2016 | -$64.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice